RHUMBLINE ADVISERS - COLLEGIUM PHARMACEUTICAL INC ownership

COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 84 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2017. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of COLLEGIUM PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2023$2,458,076
+4.9%
109,982
+0.9%
0.00%0.0%
Q2 2023$2,342,281
+95153.4%
108,994
+6.4%
0.00%0.0%
Q1 2023$2,459
+11.2%
102,481
+7.5%
0.00%0.0%
Q4 2022$2,211
-99.9%
95,296
+0.2%
0.00%
+50.0%
Q3 2022$1,524,000
-7.9%
95,107
+1.9%
0.00%0.0%
Q2 2022$1,654,000
-15.6%
93,357
-3.0%
0.00%
-33.3%
Q1 2022$1,959,000
+15.6%
96,224
+6.1%
0.00%
+50.0%
Q4 2021$1,695,000
-4.1%
90,715
+1.3%
0.00%0.0%
Q3 2021$1,768,000
-26.0%
89,556
-11.4%
0.00%
-33.3%
Q2 2021$2,389,000
-3.4%
101,051
-3.2%
0.00%0.0%
Q1 2021$2,474,000
+159.1%
104,387
+118.9%
0.00%
+200.0%
Q4 2020$955,000
-4.0%
47,695
-0.2%
0.00%
-50.0%
Q3 2020$995,000
+1.0%
47,776
-15.1%
0.00%0.0%
Q2 2020$985,000
+27.4%
56,299
+19.0%
0.00%0.0%
Q1 2020$773,000
-17.6%
47,309
+3.8%
0.00%0.0%
Q4 2019$938,000
+83.2%
45,563
+2.1%
0.00%
+100.0%
Q3 2019$512,000
-11.3%
44,620
+1.6%
0.00%0.0%
Q2 2019$577,000
-1.0%
43,914
+14.1%
0.00%0.0%
Q1 2019$583,000
-13.0%
38,482
-1.4%
0.00%0.0%
Q4 2018$670,000
+71.4%
39,018
+47.0%
0.00%0.0%
Q3 2018$391,000
-42.2%
26,541
-6.4%
0.00%0.0%
Q2 2018$676,000
+4.0%
28,341
+11.5%
0.00%0.0%
Q1 2018$650,000
+39.8%
25,425
+1.0%
0.00%0.0%
Q4 2017$465,000
+60.3%
25,183
-8.9%
0.00%0.0%
Q3 2017$290,000
-15.5%
27,633
+0.8%
0.00%0.0%
Q2 2017$343,000
+92.7%
27,403
+55.0%
0.00%
Q1 2017$178,000
-24.3%
17,679
+17.0%
0.00%
-100.0%
Q4 2016$235,000
-0.4%
15,111
+23.4%
0.00%0.0%
Q3 2016$236,000
+65.0%
12,250
+1.7%
0.00%
Q2 2016$143,00012,0500.00%
Other shareholders
COLLEGIUM PHARMACEUTICAL INC shareholders Q1 2017
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 1,887,332$34,840,0005.65%
SECTORAL ASSET MANAGEMENT INC 1,426,862$26,340,0003.29%
Eventide Asset Management 2,207,610$40,752,0002.12%
Rock Springs Capital Management LP 1,885,729$34,811,0001.58%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 460,000$8,492,0001.11%
Cormorant Asset Management, LP 300,000$5,538,0000.58%
HIGHLAND CAPITAL MANAGEMENT LP 579,234$10,693,0000.49%
TPG Group Holdings (SBS) Advisors, Inc. 1,389,863$25,657,0000.39%
NBW CAPITAL LLC 69,050$1,275,0000.34%
NEXT CENTURY GROWTH INVESTORS LLC 144,972$2,676,0000.33%
View complete list of COLLEGIUM PHARMACEUTICAL INC shareholders